Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs Diclofenac in Osteoarthritis
NCT00542087Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in osteoarthritis (OA) (2 arms), sponsored by Organon & Co. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Pain Subscale. Started Mar 2002; status: completed.
02
Drugs
etoricoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00542087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542087.